Skip to content

The effect of exercise induced extra-thoracic airway obstruction on end expiratory lung volume in children.

The effect of exercise induced extra-thoracic airway obstruction on end expiratory lung volume in children. - EIET on EELV

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON32324
Enrollment
Unknown
Registered
2008-06-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise induced airway obstruction Exercise induced asthma

Interventions

2 exercise provocation tests.

Sponsors

Medisch Spectrum Twente
Lead Sponsor

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (asthmatic subjects) - Clinical history of allergic rhinitis and/or allergic asthma. - Age between 12 and 17 years. - Ability to perform reproducible lung function tests, i.e. coefficient of the predicted value variation in 3 of 5 consecutive measurements

Exclusion criteria

Exclusion criteria: Exclusion criteria (asthmatic subjects) - Use of intranasal or systemic corticosteroids in the last 4 weeks prior to the study. - Use of antihistamines, cromoglycates, anticholinergics in two weeks prior to the study. - Use of long acting bronchodilators 24 hours before testing. - Use of short acting bronchodilators 8 hours before testing. - Other pulmonary or cardiac disorder. - Deviation of the FEV1 of more than 12 % from baseline spirometry and the FEV1 before subsequent exercise provocation challenges. - Signs of gastro-esophageal reflux. ;Exclusion criteria (healthy subjects) - Reported Illness in the past. - Exhaled NO of more than 20 ppb - Signs of gastro-esophageal reflux.

Design outcomes

Primary

MeasureTime frame
The study endpoint will be the end of the exercise provocation test, where change in MIF50 will be linked to change in EELV.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)